Skip to content

Screener

Eligibility screening

Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Sponsored by Novartis PharmaceuticalsStudy detailsClinicalTrials.gov

36 US sites in AL, AZ, CA, FL +14

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.